Literature DB >> 14578917

Changes in body weight and onset of hypertension in perimenopausal women.

M Juntunen1, L Niskanen, J Saarelainen, M Tuppurainen, S Saarikoski, R Honkanen.   

Abstract

We assessed the determinants of onset of hypertension in a large, prospective population-based study of perimenopausal women from the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. The data collection started in 1989, when a baseline postal inquiry was sent to all women aged 47-56 years (n=14 220) residing in the Kuopio Province in Eastern Finland. Names, social security numbers and addresses were obtained from the Population Register Centre of Finland. A total of 11 798 women responded at baseline and at 5-year follow-up in 1994. After the exclusion of 1777 women with prevalent hypertension at baseline and women with missing height or weight information, the study population consisted of 9485 without established hypertension at baseline. New cases of established hypertension during the follow-up (n=908) were ascertained with the Registry of Specially Refunded Drugs of the Finnish Social Insurance Institution (SII). According to the National Health Insurance, the SII granted 90% reimbursement for drug costs in defined chronic illnesses necessitating continuous medication, like arterial hypertension. Weight and weight gain both raised the risk by 5% per kg (P<0.001). Weight gain of 4-6 kg increased the risk of hypertension 1.25 times and a gain of more than 7 kg 1.65 times compared with the control (zero) group. To conclude, the onset of hypertension in peri- and early postmenopausal women was related to an increase in body weight despite controlling for initial body weight, reported physical activity and use of HRT. Therefore, preventing weight gain by dietary means and exercise is of great importance at menopausal age.

Entities:  

Mesh:

Year:  2003        PMID: 14578917     DOI: 10.1038/sj.jhh.1001611

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  5 in total

1.  Gender-specific predictive ability for the risk of hypertension incidence related to baseline level or trajectories of adiposity indices: a cohort study of functional community.

Authors:  Ya-Ke Lu; Jing Dong; Yue Sun; Li-Kun Hu; Yu-Hong Liu; Xi Chu; Yu-Xiang Yan
Journal:  Int J Obes (Lond)       Date:  2022-02-03       Impact factor: 5.095

2.  HYPEST study: profile of hypertensive patients in Estonia.

Authors:  Elin Org; Gudrun Veldre; Margus Viigimaa; Peeter Juhanson; Margus Putku; Mai Rosenberg; Kärt Tomberg; Tiina Uuetoa; Maris Laan
Journal:  BMC Cardiovasc Disord       Date:  2011-08-31       Impact factor: 2.298

3.  Inverse relationship between a genetic risk score of 31 BMI loci and weight change before and after reaching middle age.

Authors:  G Rukh; S Ahmad; U Ericson; G Hindy; T Stocks; F Renström; P Almgren; P M Nilsson; O Melander; P W Franks; M Orho-Melander
Journal:  Int J Obes (Lond)       Date:  2015-09-16       Impact factor: 5.095

4.  Development and validation of a risk score predicting substantial weight gain over 5 years in middle-aged European men and women.

Authors:  Annika Steffen; Thorkild I A Sørensen; Sven Knüppel; Noemie Travier; María-José Sánchez; José María Huerta; J Ramón Quirós; Eva Ardanaz; Miren Dorronsoro; Birgit Teucher; Kuanrong Li; H Bas Bueno-de-Mesquita; Daphne van der A; Amalia Mattiello; Domenico Palli; Rosario Tumino; Vittorio Krogh; Paolo Vineis; Antonia Trichopoulou; Philippos Orfanos; Dimitrios Trichopoulos; Bo Hedblad; Peter Wallström; Kim Overvad; Jytte Halkjær; Anne Tjønneland; Guy Fagherazzi; Laureen Dartois; Francesca Crowe; Kay-Tee Khaw; Nick Wareham; Lefkos Middleton; Anne M May; Petra H M Peeters; Heiner Boeing
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

Review 5.  Estrogen-related mechanisms in sex differences of hypertension and target organ damage.

Authors:  Andrea Rodrigues Sabbatini; Georgios Kararigas
Journal:  Biol Sex Differ       Date:  2020-06-01       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.